top of page
Non-coding RNA expression in the blood reflects which regulatory genes are overactive or underactive. FBB Biomed's proprietary analytics platform uses RNA-seq data to quantify this activity across the biological systems underlying a patient's condition. An upstream, systems-level readout no other platform delivers.
Decoding chronic disease with RNA systems biology

Who it's for

Biopharma
Stratify trial participants and monitor individual response with sharper signal

Labs
Offer liquid biopsies for neurology on existing RNA-sequencing infrastructure
FBB's platform is currently available for research use only.
Inquiries: info@FBBbio.com
2500 Crosspark Rd, UI BioVentures Center
Coralville, Iowa 52241, USA
© 2026 FBB Biomed, Inc.
bottom of page


